Clinical Trials in Cleveland

Showing 10161-10180 of 16,969 trials

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

NCT01602614

This is a clinical sampling study, and no study drugs will be administered under this protocol. Premature infants who receive intravenous ganciclovir as part of clinical care will be eligible for participation in this study. Intravenous ganciclovir will not be provided under this protocol.

Cytomegalovirus Infections

University of Alabama at Birmingham18 participantsStarted Apr 2013

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Washington D.C., District of Columbia, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Vaccine Study for Surgically Resected Pancreatic Cancer

NCT00569387

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.

Pancreatic Cancer

NewLink Genetics Corporation73 participantsStarted Dec 2007

Scottsdale, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +15 more locations

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Vaccine Study for Surgically Resected Pancreatic Cancer

Find Trials by Condition in Cleveland

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Safety Study of ECO Conversion System For Red Blood Cells.

Transvenous Lead Removal Post-Market Clinical Study

Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)